Check-Cap Ltd (7CC) - Net Assets

Latest as of December 2025: €3.44 Million EUR ≈ $4.02 Million USD

Based on the latest financial reports, Check-Cap Ltd (7CC) has net assets worth €3.44 Million EUR (≈ $4.02 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€7.49 Million ≈ $8.75 Million USD) and total liabilities (€4.05 Million ≈ $4.73 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how strategically is Check-Cap Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric Value
Current Net Assets €3.44 Million
% of Total Assets 45.91%
Annual Growth Rate -11.58%
5-Year Change -93.22%
10-Year Change N/A
Growth Volatility 109.73

Check-Cap Ltd - Net Assets Trend (2016–2025)

This chart illustrates how Check-Cap Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Check-Cap Ltd stock valuation.

Annual Net Assets for Check-Cap Ltd (2016–2025)

The table below shows the annual net assets of Check-Cap Ltd from 2016 to 2025. Also explore Check-Cap Ltd annual equity growth to track the company's year-over-year net asset growth rate.

Year Net Assets Change
2025-12-31 €3.44 Million
≈ $4.02 Million
+337.03%
2024-12-31 €-1.45 Million
≈ $-1.70 Million
-106.12%
2023-12-31 €23.69 Million
≈ $27.69 Million
-42.66%
2022-12-31 €41.31 Million
≈ $48.30 Million
-18.50%
2021-12-31 €50.69 Million
≈ $59.26 Million
+209.51%
2020-12-31 €16.38 Million
≈ $19.15 Million
+162.72%
2019-12-31 €6.23 Million
≈ $7.29 Million
-52.16%
2018-12-31 €13.03 Million
≈ $15.23 Million
+120.66%
2017-12-31 €5.91 Million
≈ $6.90 Million
-43.26%
2016-12-31 €10.41 Million
≈ $12.17 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Check-Cap Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 12292900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Other Components €169.31 Million 4926.01%
Total Equity €3.44 Million 100.00%

Check-Cap Ltd Competitors by Market Cap

The table below lists competitors of Check-Cap Ltd ranked by their market capitalization.

Company Market Cap
Solarmax Technology Inc. Common Stock
NASDAQ:SMXT
$9.20 Million
Cabnet Holdings Bhd
KLSE:0191
$9.20 Million
Vivid Games S.A
WAR:VVD
$9.20 Million
Top Shelf International Holdings Ltd
AU:TSI
$9.20 Million
Phoenix Motor Inc. Common Stock
NASDAQ:PEV
$9.20 Million
Prg Holdings Bhd
KLSE:7168
$9.19 Million
ERG S.A.
WAR:ERG
$9.19 Million
Ucloudlink Group Inc
NASDAQ:UCL
$9.18 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Check-Cap Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -1,450,000 to 3,437,000, a change of 4,887,000.
  • Net income of 4,140,000 contributed positively to equity growth.
  • Other factors increased equity by 747,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €4.14 Million +120.45%
Other Changes €747.00K +21.73%
Total Change €- %

Book Value vs Market Value Analysis

This analysis compares Check-Cap Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 10.93x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 1.45x to 10.93x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 €3.68 €5.35 x
2018-12-31 €2.45 €5.35 x
2019-12-31 €0.75 €5.35 x
2020-12-31 €0.35 €5.35 x
2021-12-31 €0.53 €5.35 x
2022-12-31 €7.07 €5.35 x
2023-12-31 €4.05 €5.35 x
2024-12-31 €-0.25 €5.35 x
2025-12-31 €0.49 €5.35 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Check-Cap Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 120.45%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 2.18x
  • Recent ROE (120.45%) is above the historical average (-34.10%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 -84.81% 0.00% 0.00x 1.18x €-9.87 Million
2017 165.47% 0.00% 0.00x 1.34x €9.18 Million
2018 -81.27% 0.00% 0.00x 1.18x €-11.89 Million
2019 -221.94% 0.00% 0.00x 1.51x €-14.46 Million
2020 -84.54% 0.00% 0.00x 1.20x €-15.48 Million
2021 -33.94% 0.00% 0.00x 1.10x €-22.27 Million
2022 -46.25% 0.00% 0.00x 1.10x €-23.24 Million
2023 -74.17% 0.00% 0.00x 1.06x €-19.94 Million
2024 0.00% 0.00% 0.00x 0.00x €-25.00 Million
2025 120.45% 0.00% 0.00x 2.18x €3.80 Million

Industry Comparison

This section compares Check-Cap Ltd's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

  • Industry: Diagnostics & Research
  • Average net assets among peers: $4,316,491,440
  • Average return on equity (ROE) among peers: -58.29%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Check-Cap Ltd (7CC) €3.44 Million -84.81% 1.18x $9.20 Million
IZOTROPIC CORP. (1R3) $-374.59K 0.00% 0.00x $8.87 Million
ALPHAHELIX MOL.DIAGN. SK1 (4MB) $10.41 Million -90.99% 0.83x $991.78K
HANGZHOU TIGERMED CO. H 1 (5HZ1) $24.26 Billion 3.66% 0.17x $685.18 Million
INTERGRATED DIA.H DL 025 (8I8) $2.79 Billion 50.55% 1.23x $288.34 Million
GENETIC ANALYSIS NK -60 (8V8) $44.14 Million -64.05% 0.46x $2.36 Million
GENINCODE PLC LS -01 (9PL) $1.13 Million -393.43% 1.36x $6.02 Million
INOVIQ LTD. (EGQ0) $19.62 Million -45.73% 0.10x $13.74 Million
Eurofins Scientific SE (ESF0) $2.48 Billion 8.73% 1.35x $11.18 Billion
ICON Public Limited Company (IJF) $9.24 Billion 6.63% 0.84x $7.52 Billion

About Check-Cap Ltd

F:7CC Germany Diagnostics & Research
Market Cap
$48.35 Million
€41.36 Million EUR
Market Cap Rank
#27375 Global
#2352 in Germany
Share Price
€5.35
Change (1 day)
+0.00%
52-Week Range
€0.82 - €7.80
All Time High
€736.32
About

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.